Drug Shortage Report for RAN-GABAPENTIN
Report ID | 19636 |
Drug Identification Number | 02319055 |
Brand name | RAN-GABAPENTIN |
Common or Proper name | RAN-GABAPENTIN |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-10-29 |
Actual start date | 2018-10-29 |
Estimated end date | 2019-01-15 |
Actual end date | 2018-12-03 |
Shortage status | Resolved |
Updated date | 2019-02-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.